ProShare Advisors’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.16M Sell
32,245
-516
-2% -$18.6K ﹤0.01% 772
2025
Q1
$1.29M Sell
32,761
-9,194
-22% -$363K ﹤0.01% 749
2024
Q4
$1.26M Buy
41,955
+12,951
+45% +$390K ﹤0.01% 827
2024
Q3
$678K Buy
29,004
+10,429
+56% +$244K ﹤0.01% 961
2024
Q2
$330K Sell
18,575
-6,339
-25% -$113K ﹤0.01% 1219
2024
Q1
$379K Buy
24,914
+1,961
+9% +$29.8K ﹤0.01% 1265
2023
Q4
$392K Buy
22,953
+5,127
+29% +$87.6K ﹤0.01% 1199
2023
Q3
$149K Sell
17,826
-21
-0.1% -$176 ﹤0.01% 1552
2023
Q2
$443K Buy
17,847
+2,171
+14% +$53.9K ﹤0.01% 1021
2023
Q1
$236K Sell
15,676
-1,453
-8% -$21.9K ﹤0.01% 1355
2022
Q4
$203K Buy
17,129
+2,443
+17% +$28.9K ﹤0.01% 1494
2022
Q3
$87K Sell
14,686
-277
-2% -$1.64K ﹤0.01% 1590
2022
Q2
$64K Sell
14,963
-9,332
-38% -$39.9K ﹤0.01% 1672
2022
Q1
$231K Sell
24,295
-4,002
-14% -$38.1K ﹤0.01% 1797
2021
Q4
$537K Buy
28,297
+11,869
+72% +$225K ﹤0.01% 1390
2021
Q3
$547K Sell
16,428
-16,828
-51% -$560K ﹤0.01% 1151
2021
Q2
$1.29M Buy
33,256
+711
+2% +$27.6K ﹤0.01% 896
2021
Q1
$1.57M Buy
32,545
+7,007
+27% +$338K ﹤0.01% 778
2020
Q4
$1.33M Buy
25,538
+11,925
+88% +$620K ﹤0.01% 765
2020
Q3
$364K Buy
13,613
+485
+4% +$13K ﹤0.01% 1074
2020
Q2
$256K Buy
+13,128
New +$256K ﹤0.01% 1321
2020
Q1
Sell
-11,682
Closed -$130K 1546
2019
Q4
$130K Buy
+11,682
New +$130K ﹤0.01% 1662
2014
Q3
Sell
-11,442
Closed -$107K 2353
2014
Q2
$107K Sell
11,442
-4,296
-27% -$40.2K ﹤0.01% 2342
2014
Q1
$109K Buy
+15,738
New +$109K ﹤0.01% 2676